Work

Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study

Year: 2022

Type: article

Study design: Observational Study

Source: Journal of Dermatological Treatment

DOI: 10.1080/09546634.2022.2081655

Authors: Matteo Megna, Nello Tommasino, Luca Potestio, Teresa Battista, Angelo Ruggiero, Matteo Noto, Gabriella Fabbrocini, Lucia Genco

Institution: University of Naples Federico II

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281288090

FWCI: 7.135

Cites: 29

Cited by: 90

Related to: 10